Activity
-
At Generate:Biomedicines, we are fortunate to work with some of the most amazing scientists and professionals in the biotech industry. Today was a…
At Generate:Biomedicines, we are fortunate to work with some of the most amazing scientists and professionals in the biotech industry. Today was a…
Liked by Russell Chong
-
It’s hard to believe that it has been more than three months since I've stepped into my role. I’ve taken this time to get to know the business, but…
It’s hard to believe that it has been more than three months since I've stepped into my role. I’ve taken this time to get to know the business, but…
Liked by Russell Chong
-
Exciting progress for Evommune in our fight against inflammatory diseases
Exciting progress for Evommune in our fight against inflammatory diseases
Liked by Russell Chong
Experience & Education
More activity by Russell
-
💎 Tiffany Welch is a member of EWiT Diamond! As a Professional Leadership Coach, Tiffany empowers women leaders in technology. With 25 years in…
💎 Tiffany Welch is a member of EWiT Diamond! As a Professional Leadership Coach, Tiffany empowers women leaders in technology. With 25 years in…
Liked by Russell Chong
-
We are thrilled to welcome Nadia Lachman to the Amplitude Ventures team. Nadia is based in Calgary and will be working with and supporting the entire…
We are thrilled to welcome Nadia Lachman to the Amplitude Ventures team. Nadia is based in Calgary and will be working with and supporting the entire…
Liked by Russell Chong
-
We are excited to share that Avista Capital Partners has promoted Gillian Gude to Senior Associate and Harrison Brenner to Vice President…
We are excited to share that Avista Capital Partners has promoted Gillian Gude to Senior Associate and Harrison Brenner to Vice President…
Liked by Russell Chong
-
Eli Lilly to acquire Morphic Therapeutic, a biopharmaceutical company developing oral integrin therapies for treatment of serious chronic…
Eli Lilly to acquire Morphic Therapeutic, a biopharmaceutical company developing oral integrin therapies for treatment of serious chronic…
Liked by Russell Chong
-
Very proud of the individuals who make up the Modellus Novus team. Thank you for your commitment to excellent design and reshaping how architecture…
Very proud of the individuals who make up the Modellus Novus team. Thank you for your commitment to excellent design and reshaping how architecture…
Liked by Russell Chong
-
Forbion is pleased to announce that we have led a $170 million in Series B funding for Beacon Therapeutics. We were joined by TCGX, and Advent Life…
Forbion is pleased to announce that we have led a $170 million in Series B funding for Beacon Therapeutics. We were joined by TCGX, and Advent Life…
Liked by Russell Chong
-
Speaker Announcement We are excited to Quyen Tran at TIDE SPARK 2024. Quyen Tran is Principal of Capital Formation and Investor Relations at…
Speaker Announcement We are excited to Quyen Tran at TIDE SPARK 2024. Quyen Tran is Principal of Capital Formation and Investor Relations at…
Liked by Russell Chong
-
Another successful exit! It’s been a fun ride with Tariq Kassum, Jeanne Magram, the Celsius Therapeutics team and the rest of the board and…
Another successful exit! It’s been a fun ride with Tariq Kassum, Jeanne Magram, the Celsius Therapeutics team and the rest of the board and…
Liked by Russell Chong
Other similar profiles
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore MoreOthers named Russell Chong in United States
-
Russell Chong
Principal Research Chemist at Covidien
-
Russell G. Chong
Available for work
-
Russell Chong
Retired at Federal Government
-
Russ Chong
5 others named Russell Chong in United States are on LinkedIn
See others named Russell Chong